Insulet | PODD - Capital Y Las Reservas

Precio De Mercado
160.02
Cambio Diario
-22.85 -12.50%
Mensual
-23.07%
Anual
-36.57%
Q2 Expectativa
185.50




Capital Y Las Reservas Cambio Fecha
Abbott USD 52.06B 69M 2026-03
Align Technology USD 4.05B 91.69M 2025-12
AtriCure USD 491.94M 15.43M 2025-12
Avanos Medical USD 778.2M 200K 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Boston Scientific USD 24.23B 1.58B 2025-12
Cardinal Health USD -2.88B 5M 2025-12
Cooper Companies USD 8.36B 124.7M 2025-12
Dexcom USD 2.75B 19.9M 2025-12
Edwards Lifesciences USD 10.34B 132.6M 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Globus Medical USD 4.57B 174.42M 2025-12
ICU Medical USD 2.12B 3.42M 2025-12
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.52B 131.1M 2025-12
Integra LifeSciences USD 1.04B 5.89M 2025-12
J&J USD 81.19B 358M 2026-03
Masimo USD 721.2M 88.8M 2025-12
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.58B 54.9M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Solventum Corp USD 5.05B 63M 2025-12
Stryker USD 21.78B 594M 2025-09
Tandem Diabetes Care USD 155.17M 22.2M 2025-12
Teleflex USD 3.12B 697.09M 2025-12
West Pharmaceutical Services USD 2.99B 185.6M 2026-03
Zimmer Biomet Holdings USD 12.68B 16.1M 2026-03